期刊文献+

雷帕霉素对诱导nave小鼠效应性T细胞转化为调节性T细胞的影响 被引量:1

Effect of Rapamycin in Inducing Nave Murine Effector T Cell Convert to Regulatory T Cell
下载PDF
导出
摘要 目的研究雷帕霉素对诱导naive小鼠效应性T细胞(Teff)体外转化为调节性T细胞(Treg)的影响。方法取6-8周龄C57BL/6小鼠的脾及淋巴结,分离提纯叉头蛋白3(FoxP3)阴性的Teff,分为与成熟树突状细胞(mDC)、B细胞和抗CD3抗体(Anti-CD3)共培养3组,前两组6 d后收获细胞,Anti-CD3组4 d后收获细胞。每组设对照组与实验组,对照组未加入雷帕霉素,实验组加入雷帕霉素,使其浓度分别为1、10、50、100 nmol/L,流式细胞仪检测收获细胞中FoxP3阳性的Treg比率。结果FoxP3阳性的Treg细胞比率:在mDC组中对照组为0.01%,实验组分别为0.39%、0.47%、0.34%、0.26%;在B细胞组中对照组为0.01%,实验组分别为5.56%、5.89%、7.15%、4.72%;在Anti-CD3组中对照组为0.93%,实验组分别为1.35%、1.07%、1.02%、1.19%。mDC组及Anti-CD3组各实验组与对照组相比差异无显著性,B细胞组中各实验组与对照组相比差异具有显著性(P〈0.01)。结论在体外以B细胞作为抗原呈递细胞,雷帕霉素能够诱导naive小鼠Teff转化为FoxP3阳性的Treg。 Objective To study the effect of rapamycin in inducing naive murine effector T cell(Teff) convert to regulatory T cell(Treg) in vitro.Methods The forkhead box protein 3(FoxP3) negative Teff were isolated and purified from the spleen and lymph node of C57BL/6 murines aged 6-8 weeks,then Teff were cultured in three groups with mature dendritic cells(mDC),B cells,and plate coated Anti-CD3.In addition,the control wells and the test wells were prepared in each group,rapamycin were not added in the control wells but added in the test wells with concentrations of 1,10,50,and 100 nmol/L.Percentages of FoxP3 positiveTreg were examined by flow cytometry after 4 days in Anti-CD3 group and after 6 days in the other two groups.Results As shown by the flow cytometry,the percentages of Fox P3 positive Treg were as follows in three group: in the mDC group,it was 0.01% in the control well and 0.39%,0.47%,0.34%,and 0.26% in test wells;in B cell group,it was 0.01% in the control wells and 5.56%,5.89%,7.15%,and 4.72% in the test wells;in Anti-CD3 group,it was 0.93% in the control wells and 1.35%,1.07%,1.02%,and 1.19% in test wells.No significant difference was found between the test wells and control wells in the mDC group and Anti-CD3 group;however,the percentages of FoxP3 positive Treg was significantly different between the test wells and control wells in the B cell group(P〈0.01).Conclusion When B cell is acted as the antigen-presenting cell,rapamycin can effectively induce Teff convert to Treg in vitro.
出处 《中国医学科学院学报》 CAS CSCD 北大核心 2008年第4期393-399,共7页 Acta Academiae Medicinae Sinicae
基金 国家自然科学基金(30772050)~~
关键词 雷帕霉素 效应性T细胞 调节性T细胞 叉头蛋白3 rapamycin effector T cell regulatory T cell forkhead box protein 3
  • 相关文献

参考文献23

  • 1Flechner SM, Goldfarb D, Modlin C, et al. Kidney transplantion without calcineurin inhibitor drugs: a prospective randomized trail of sirohmus versus cyclosperine [ J]. Transplant, 2002, 74 (8) : 1070-1076.
  • 2陆莉,林志彬.雷帕霉素对小鼠脾淋巴细胞增殖及产生细胞因子的影响[J].中国药理学通报,2001,17(3):266-268. 被引量:4
  • 3Strauss L, Whiteside TL, Knights A, et al. Selective survival of naturally occurring human CD4^+ CD25^+ FoxP3^+ regulatory T cells cultured with rapamycin [ J ]. J Immunol, 2007, 178(1) :320-329.
  • 4Battaglia M, Stabilini A, Migliavacca B, et al. Rapamycin promotes expansion of functional CD4^+ CD25^+ FOXP3^+ regulatory T cells of both healthy subjects and type 1 diabetic patients [ J]. J Immunol, 2006, 177 (12) :8338-8347.
  • 5Oliveira V, Agua-Doce A, Duarte J, et al. Regulatory T cell maintenance of dominant tolerance: induction of tissue self-defense [J]. Transpl Immunol, 2006, 17(1) :7-10.
  • 6Kingsley CI, Karim M, Bushell AR, et al. CD25^+ CD4^+ regulatory T cells prevent graft rejection: CTLA-4 and IL-10 dependent immunoregulation of alloresponses [ J]. J Immunol, 2002, 168(3):1080-1086.
  • 7Cobbold S, Waldmann H. Infectious tolerance [J]. Curr Opin Immunol, 1998, 10(5) :518-524.
  • 8Graca L, Cobbold SP, Waldmann H. Identification of regulatory T cells in tolerated allografts [ J]. J Exp Med, 2002, 195 (12) : 1641-1646.
  • 9Zheng XX, Sanchez-Fueyo A, Domenig C, et al. The balance of deletion and regulation in allograft tolerance [ J ]. Immunol Rev, 2003, 196(1) :75-84.
  • 10Sanchez-Fueyo A, Weber M, Domenig C, et al. Tracking the immunoregulatory mechanisms active during allograft tolerance [J]. J Immunol, 2002, 168(5):2274-2281.

二级参考文献14

  • 1Flens MJ,Mulder WM,Bril H,etal.Efficient expansion of tumor-infiltrating lymphocytes from solid tumors by stimulationwith combined CD3 and CD28 monoclonal antibodies.Cancer Immunol Immunother,1993;37:323-328
  • 2Garlie NK,LeFever AV,Siebenlist RE,et al.T cells co-activated with immobilized anti-CD3 and anti-CD28 as potential immunotherapy for cancer.J Immunotherapy,1999; 22:336-345
  • 3Ramireddy R,Doctschman T.TGF-b,T-cell tolerance and anti CD3 therapy.Trends MolMed,2004; 10:3-9
  • 4Suarez-Pinzon WL,Marcoux Y,Ghahary A.Gene transfection and expression of transforminggrowth factor-β1 in nonobese diabetic mouse islets protects β-cells in syngeneic isletgrafts from autoimmune destruction.Cell Transplant,2002; 11:519-528
  • 5Green EA,Gorelik L,McGregor CM,et al.CD4^+ CD25^+ T regulatory cell control anti-islet CD8^+ T cells through TGF-β-TGF-βreceptor interactions in type 1 diabetes.Proc Natl AcadSci USA,2003; 100:10878-10883
  • 6Belghith M,Bluestone JZ,Barriot S,et al.TGF-β-dependent mechanisms mediate restorationof self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes.Nat Med,2003;9:1202-1208
  • 7Annunziato F,Cosmi L,Liotta F,et al.Phenotype,localization,and mechanism ofsuppression of CD4^+ CD25^+ human thymocytes.J Exp Med,2002; 196:379 -387
  • 8Piccirillo CA,Letterio JJ,Thornton AM,et al.CD4^+ CD25^+ regulatory T cells canmediate suppressor function in the absence of transforming growth factor betal productionand responsiveness.J Exp Med,2002; 196:237-246
  • 9Thompson C,Powrie F.Regulatory T cells.Cur Opin Pharmacol,2004; 4:408 -414
  • 10Bisikirska B,Colgan J,Luban J,et al.TCR stimulation with modified anti-CD3 mAb expands CD8^+ T cell population and induces CD8^+ CD25^+ Tregs.J Clin Invest,2005; 115:2904-2913

共引文献9

同被引文献12

  • 1Vang KB,Yang J,Mahmud SA,et al.IL-2,-7 and IL-15,but not thymic stromal lymphopoeitin,redundantly govern CD4^+ Foxp3^+ regulatory T cell development[J].J Immunol,2008,181(5):3285-3290.
  • 2Suntharalingam G,Perry MR,Ward S,et al.Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412[J].N Engl J Med,2006,355(10):1018-1028.
  • 3Karagiannis TC,El-Osta A.Clinical potential of histone deacetylase inhibitors as stand alone therapeutics and in combination with other chemotherapeutics or radiotherapy for cancer[J].Epigenetics,2006,1(3):121-126.
  • 4Battaglia M,Stabilini A,Migliavacca B,et al.Rapamycin promotes expansion of functional CD4^+CD25^+ FOXP3^+ regulatory T cells of both healthy subjects and type 1 diabetic patients[J].J Immunol,2006,177(12):8338-8347.
  • 5D'Alessio FR,Tsushima K,Aggarwal NR,et al.CD4^+ CD25^+ FOXP3^+ Tregs resolve experimental lung injury in mice and are present in humans with acute lung injury[J].J Clin Invest,2009,119(10):2898-2913.
  • 6Abe Y,Urakami H,Ostanin D,et al.Induction of Foxp3-expressing regulatory T-cells by donor blood transfusion is required for tolerance to rat liver allografts[J].PLoS One,2009,4(11):e7840.
  • 7Long KZ,Rosado JL,Santos JI,et al.Associations between mucosal innate and adaptive immune responses and resolution of diarrheal pathogen infections[J].Infect Immun,2009,78(3):1221-1228.
  • 8Bakke AC,Purtzer MZ,Wildin RS.Prospective immunological profiling in a case of immune dysregulation,polyendocrinopathy,enteropathy,X-linked syndrome (IPEX)[J].Clin Exp Immunol,2004,137(2):373-378.
  • 9Corthay A.How do Regulatory T Cells Work?[J].Scand J Immunol,2009,70(4):326-36.
  • 10Laura Strauss,Malgorzata Czystowska,et al.Whiteside.Differential Responses of Human Regulatory T Cells (Treg) and Effector T Cells to Rapamycin[J].PLoS ONE,2009,4(6):e5994.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部